ARWR

Arrowhead Research (ARWR) with September $35 calls adding 3000X on 4/4 to the 2000 bought on 3/18 while April $30 calls are still holding 4000X...

Arrowhead Pharmaceuticals (ARWR) shares with a strong 20% move higher last week though still down 30% YTD and worked out of a multi-month downtrend after...

Arrowhead Pharma (ARWR) shares recently fell 30% after pausing its RNAi therapeutics candidate in Cystic-Fibrosis due to lung inflammation but worth looking closer as a...

The Pfizer (PFE) deal for Array (ARRY) was one of the most interesting deals as it came at a strong 60% premium and options activity...